<result><Target><Item><Target_ID> 1476</Target_ID>
<Target_Name>The anticodon stem and loop of human tRNA(Lys3), ASL(Lys3)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1477</Target_ID>
<Target_Name>ASL(Lys3) (s2U34;Ψ39)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The modified ASL target is a 17 nucleotide, human ASL tRNA(Lys3) with s2U34 and Ψ39.</Comments>
</Item><Item><Target_ID> 1478</Target_ID>
<Target_Name>ASL(Lys3) (UUU-ms2t6A37;mcm5s2U34;Ψ39)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The htRNA(Lys3) (UUU) with the anticodon UUU is one of some 45 tRNAs. Mature htRNA(Lys3) (UUU) contains the naturally occurring post-transcriptional modifications 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U34) at wobble position 34 and 2-methylthio-N6-threonylcarbamoyladenosine (ms2t6A37) at position 37 within the tRNA\'s anticodon stem and loop domain. Pseudouridine, Ψ39 is locatet at position 39, 3′to the anticodon loop.</Comments>
</Item><Item><Target_ID> 1479</Target_ID>
<Target_Name>Anti-DENV E EDIII HuScFv</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human single-chain variable fragments (HuScFv) with inhibitory effect to DENV infection were generated. HuScFv molecules were screened and selected from the human antibody phage display library by using purified recombinant DENV EDII proteins as target antigens for biopanning.</Comments>
</Item><Item><Target_ID> 1480</Target_ID>
<Target_Name>Human breast carcinoma SKBR-3 (HER positive) cells</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1481</Target_ID>
<Target_Name>Human synovium-derived mesenchymal stem cells, hSMSCs</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Human SMSCs (hSMSCs) were isolated from eight patients (three males and five females, aged 60.38 ± 6.28 years with an age range of 50-73 years) who underwent total knee arthroplasty.</Comments>
</Item><Item><Target_ID> 1482</Target_ID>
<Target_Name>Anti-Claudin 18.2 monoclonal antibody IMAB362</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>IMAB362 (anti-Claudin 18.2) is a highly tumor-specific monoclonal IgG1 antibody currently in clinical development for the treatment of advanced gastro-esophageal and stomach cancer. The antibody is directed against the cancer-specific cell surface target Claudin 18 isoform 2 (CLDN18.2), a 27.7 kDa gastric differentiation protein that spans the cell membrane with four transmembrane helices. IMAB362 is derived from a murine monoclonal antibody, and has been chimerized to display the human IgG1 constant region. For clinical development, IMAB362 is produced in Chinese Hamster Ovary (CHO) cells by standard recombinant expression technology.</Comments>
</Item><Item><Target_ID> 1483</Target_ID>
<Target_Name>Fc region of human immunoglobulin G (IgG)</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1484</Target_ID>
<Target_Name>Human glioblastoma cell line A172</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1485</Target_ID>
<Target_Name>IgG from cerebro spinal fluid of multiple sclerosis (MS) patient 1</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606 </Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1486</Target_ID>
<Target_Name>IgG from cerebro spinal fluid of multiple sclerosis (MS) patient 2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1487</Target_ID>
<Target_Name>IgG from a mixture of 20 different CSF of multiple sclerosis (MS) patients</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1488</Target_ID>
<Target_Name>Tyrosyl-tRNA synthetase, TyrRS</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Tyrosyl-tRNA synthetase (TyrRS) from H. influenzae catalyzes the charging of the amino acid tyrosine to tRNA(Tyr).</Comments>
</Item><Item><Target_ID> 1489</Target_ID>
<Target_Name>Proline--tRNA ligase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P16659</Target_Sequence>
<Synonyms>Global RNA synthesis factor
Prolyl-tRNA synthetase
ProRS
EC=6.1.1.15</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Prolyl-tRNA synthetase (ProRS) from E. coli catalyzes the charging of the amino acid proline to tRNA(Pro).</Comments>
</Item><Item><Target_ID> 1490</Target_ID>
<Target_Name>Alcohol dehydrogenase 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00331</Target_Sequence>
<Synonyms>Alcohol dehydrogenase II
EC=1.1.1.1
YADH-2</Synonyms>
<Target_Source>Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast):559292</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Alcohol dehydrogenase (ADH) from Saccharomyces cerevisiae catalyzes the conversion of ethanol to acetaldehyde using NAD+ as a cofactor.</Comments>
</Item><Item><Target_ID> 1491</Target_ID>
<Target_Name>β-glucosidase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>β-Glucosidase from  Agrobacterium faecalis catalyzes the hydrolysis of β-glucosides.</Comments>
</Item><Item><Target_ID> 1492</Target_ID>
<Target_Name>Hexokinase-1 and hexokinase-2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>Hexokinase-1: P04806, Hexokinase-2: P04807</Target_Sequence>
<Synonyms>Alternative name(s) of Hexokinase-1:
Hexokinase PI
Hexokinase-A
Alternative name(s) of Hexokinase-2:
Hexokinase PII
Hexokinase-B</Synonyms>
<Target_Source>Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast):559292</Target_Source>
<Target_Structure>Hexokinase-1: 1HKG, 3B8A
Hexokinase-2: 1IG8, 2YHX</Target_Structure>
<Comments>Hexokinase (HK) from S. cerevisiae catalyzes the phosphorylation of D-glucose by ATP to yield D-glucose 6-phosphate.</Comments>
</Item><Item><Target_ID> 1493</Target_ID>
<Target_Name>Glycogen phosphorylase, muscle form</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P00489</Target_Sequence>
<Synonyms>Myophosphorylase
EC=2.4.1.1</Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure>1A8I, 1ABB, 1AXR, 1B4D, 1BX3, 1C50, 1C8K, 1C8L, 1E1Y, 1FS4, 1FTQ, 1FTW, 1FTY, 1FU4, 1FU7, 1FU8, 1GFZ, 1GG8, 1GGN, 1GPA, 1GPB, 1GPY, 1H5U, 1HLF, 1K06, 1K08, 1KTI, 1LWN, 1LWO, 1NOI, 1NOJ, 1NOK, 1P29, 1P2B, 1P2D, 1P2G, 1P4G, 1P4H, 1P4J, 1PYG, 1UZU, 1WUT, 1WUY, 1WV0, 1WV1, 1WW2, 1WW3, 1XC7, 1XKX, 1XL0, 1XL1, 1Z62, 1Z6P, 1Z6Q, 2AMV, 2F3P, 2F3Q, 2F3S, 2F3U, 2FET, 2FF5, 2FFR, 2G9Q, 2G9R, 2G9U, 2G9V, 2GJ4, 2GM9, 2GPA, 2GPB, 2GPN, 2IEG, 2IEI, 2OFF, 2PRI, 2PRJ, 2PYD, 2PYI, 2QLM, 2QLN, 2QN1, 2QN2, 2QN3, 2QN7, 2QN8, 2QN9, 2QNB, 2QRG, 2QRH, 2QRM, 2QRP, 2QRQ, 2SKC, 2SKD, 2SKE, 3AMV, 3BCR, 3BCS, 3BCU, 3BD6, 3BD7, 3BD8, 3BDA, 3CUT, 3CUU, 3CUV, 3CUW, 3E3L, 3E3N, 3E3O, 3EBO, 3EBP, 3G2H, 3G2I, 3G2J, 3G2K, 3G2L, 3G2N, 3GPB, 3L79, 3L7A, 3L7B, 3L7C, 3L7D, 3MQF, 3MRT, 3MRV, 3MRX, 3MS2, 3MS4, 3MS7, 3MSC, 3MT7, 3MT8, 3MT9, 3MTA, 3MTB, 3MTD, 3NC4, 3NP7, 3NP9, 3NPA, 3S0J, 3SYM, 3SYR, 3T3D, 3T3E, 3T3G, 3T3H, 3T3I, 3ZCP, 3ZCQ, 3ZCR, 3ZCS, 3ZCT, 3ZCU, 3ZCV, 4EJ2, 4EKE, 4EKY, 4EL0, 4EL5, 4GPB, 4MRA, 5GPB, 6GPB, 7GPB, 8GPB, 9GPB</Target_Structure>
<Comments>Glycogen phosphorylase a (Pa) from rabbit muscle catalyzes the removal and phosphorylation of the terminal glucose residue of glycogen to generate glucose-1-phosphate.</Comments>
</Item><Item><Target_ID> 1494</Target_ID>
<Target_Name>Carboxypeptidase B</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P09955</Target_Sequence>
<Synonyms>EC=3.4.17.2</Synonyms>
<Target_Source>Sus scrofa (Pig):9823</Target_Source>
<Target_Structure>1NSA, 1PBA, 1Z5R, 1ZG7, 1ZG8, 1ZG9, 2JEW, 2PIY, 2PIZ, 2PJ0, 2PJ1, 2PJ2, 2PJ3, 2PJ4, 2PJ5, 2PJ6, 2PJ7, 2PJ8, 2PJ9, 2PJA, 2PJB, 2PJC, 3GLJ, 3WAB, 3WC5, 3WC6, 3WC7</Target_Structure>
<Comments>Carboxypeptidase B (CPB) is a metalloprotease that cleaves proteins adjacent to arginine and lysine residues.</Comments>
</Item><Item><Target_ID> 1495</Target_ID>
<Target_Name>MRNA of amyloid precursor protein (APP)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of amyloid precursor protein (APP) has 48 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1496</Target_ID>
<Target_Name>MRNA of hepatitis C virus (HCV)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of hepatitis C virus (HCV) has 51 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1497</Target_ID>
<Target_Name>MRNA of insulin-like growth factor-1 (IGF-1)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of insulin-like growth factor-1 (IGF-1) has 61 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1498</Target_ID>
<Target_Name>MRNA of Rev Response Element (RRE)</Target_Name>
<Target_Type>Nucleic acids</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target mRNA of Rev Response Element (RRE) has 47 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</Comments>
</Item><Item><Target_ID> 1499</Target_ID>
<Target_Name>RIP1-Tag2 tumors</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>RIP1-Tag2 mice develop multifocal angiogenic islet progenitors and then solid tumors in a stepwise manner, such that at 12 weeks of age, each mouse will typically have approximately 50 angiogenic islets and 2–6 small tumors. This circumstance allowed us to use 12-week-old mice to select for phage binding to angiogenic islet progenitors and/or tumors in the same mouse.</Comments>
</Item><Item><Target_ID> 1500</Target_ID>
<Target_Name>RIP1-Tag2 angiogenic islets</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>RIP1-Tag2 mice develop multifocal angiogenic islet progenitors and then solid tumors in a stepwise manner, such that at 12 weeks of age, each mouse will typically have approximately 50 angiogenic islets and 2–6 small tumors. This circumstance allowed us to use 12-week-old mice to select for phage binding to angiogenic islet progenitors and/or tumors in the same mouse.</Comments>
</Item></Target></result>